KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Tax Provisions: 2016-2024

Historic Tax Provisions for BeOne Medicines (ONC) over the last 8 years, with Dec 2024 value amounting to $111.8 million.

  • BeOne Medicines' Tax Provisions fell 3.14% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.7 million, marking a year-over-year increase of 83.30%. This contributed to the annual value of $111.8 million for FY2024, which is 100.07% up from last year.
  • BeOne Medicines' Tax Provisions amounted to $111.8 million in FY2024, which was up 100.07% from $55.9 million recorded in FY2023.
  • BeOne Medicines' 5-year Tax Provisions high stood at $111.8 million for FY2024, and its period low was $10.4 million during FY2020.
  • Moreover, its 3-year median value for Tax Provisions was $55.9 million (2023), whereas its average is $70.1 million.
  • Data for BeOne Medicines' Tax Provisions shows a peak YoY soared of 100.07% (in 2024) over the last 5 years.
  • Over the past 4 years, BeOne Medicines' Tax Provisions (Yearly) stood at $10.4 million in 2020, then reached $42.8 million in 2022, then soared by 30.61% to $55.9 million in 2023, then surged by 100.07% to $111.8 million in 2024.